Furthermore, TAF9 overexpression markedly increased fatty acid β-oxidation and attenuated HFD- and PA-induced NAFLD, suggesting that TAF9-mediated fatty acid β-oxidation promotion plays crucial roles in NAFLD. Here, TAF9 is linked to metabolic dysfunction-associated steatotic liver disease.